Transferrin functionalization enhances prostate cancer cell uptake and cytotoxicity of cabazitaxel-loaded polymeric nanoparticles.

Barroso de Freitas JV, Holanda VM, Matos de França AB, Moreira TDS, Cruz de Souza AC, Juvêncio BA, de Araujo Nobre AR, da Silva Ribeiro FO, Petrilli R, Eloy JO

Open source

DOI
10.1016/j.ijpharm.2026.127583
Published
2026 Oct 25
Container
International journal of pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127583,
  title = {Transferrin functionalization enhances prostate cancer cell uptake and cytotoxicity of cabazitaxel-loaded polymeric nanoparticles.},
  author = {Barroso de Freitas JV and Holanda VM and Matos de França AB and Moreira TDS and Cruz de Souza AC and Juvêncio BA and de Araujo Nobre AR and da Silva Ribeiro FO and Petrilli R and Eloy JO},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127583},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127583}
}

RIS

TY  - JOUR
TI  - Transferrin functionalization enhances prostate cancer cell uptake and cytotoxicity of cabazitaxel-loaded polymeric nanoparticles.
AU  - Barroso de Freitas JV
AU  - Holanda VM
AU  - Matos de França AB
AU  - Moreira TDS
AU  - Cruz de Souza AC
AU  - Juvêncio BA
AU  - de Araujo Nobre AR
AU  - da Silva Ribeiro FO
AU  - Petrilli R
AU  - Eloy JO
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127583
UR  - https://doi.org/10.1016/j.ijpharm.2026.127583
ER  - 

APA

JV, B. D. F., VM, H., AB, M. D. F., TDS, M., AC, C. D. S., BA, J., AR, D. A. N., FO, D. S. R., R, P., & JO, E. (2026). Transferrin functionalization enhances prostate cancer cell uptake and cytotoxicity of cabazitaxel-loaded polymeric nanoparticles.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127583

Source records